Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappa B-independent mechanisms Article

cited authors

  • Takigawa, Nagio; Vaziri, Susan A. J.; Grabowski, Dale R.; Chikamori, Kenichi; Rybicki, Lisa R.; Bukowski, Ronald M.; Ganapathi, Mahrukh K.; Ganapathi, Ram; Mekhail, Tarek

authors

Publication Date

  • May 1, 2006

webpage

published in

category

keywords

  • CPT-11
  • NF-kappa B
  • PS-341
  • bortezomib
  • irinotecan
  • p53
  • proteasome
  • survivin
  • topoisomerase 1

start page

  • 1869

end page

  • 1876

volume

  • 26

issue

  • 3A